TALPHERA, INC. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
TALPHERA, INC. (TLPH) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $196.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2025-03-31
- TALPHERA, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $196.00K, a 24.84% increase from fiscal 2023.
- TALPHERA, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $157.00K, a 265.12% increase from fiscal 2022.
- TALPHERA, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $43.00K.
- TALPHERA, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2020 was $0.00.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2024-12-31 | $196.00K 10-K · filed 2025-03-31 |
| 2023-12-31 | $157.00K 10-K · filed 2025-03-31 |
| 2022-12-31 | $43.00K 10-K · filed 2024-03-06 |
| 2021-12-31 | $0.00 8-K · filed 2023-08-01 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-15 |
| 2018-12-31 | $213.00K 10-K · filed 2021-03-15 |
| 2017-12-31 | $203.00K 10-K · filed 2020-03-16 |
| 2016-12-31 | $223.00K 10-K · filed 2019-03-07 |
| 2015-12-31 | $272.00K 10-K · filed 2018-03-09 |
| 2014-12-31 | $326.00K 10-K · filed 2017-03-03 |
| 2013-12-31 | $310.00K 10-K · filed 2016-03-07 |
| 2012-12-31 | $79.00K 10-K · filed 2015-03-13 |
| 2011-12-31 | $145.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |